Matthew Yglesias @mattyglesias
Since demonstrating efficacy is time-consuming and expensive, one view — a general view not unique to Covid — is we should shift to a pure safety standard that makes it easier to bring things to market. If it’s safe what’s the harm? — PolitiTweet.org